Abstract
Fifty asymptomatic, pediatric hemophiliacs were examined for distribution of T-cell subsets, responsiveness to mitogen stimulation, interleukin-2 production, hypergammaglobulinemia, and the presence of antibody to virus including the human T-lymphotrophic virus type III (HTLV-III). Hemophilia A patients receiving factor VIII concentrate as replacement therapy had the most pronounced changes including decreased T4/T8 ratios and lowerin vitro responsiveness to both phytohemagglutinin and pokeweed mitogen. Hemophilia A patients treated with cryoprecipitate and hemophilia B patients did not demonstrate these changes. Regardless of replacement therapy, hemophiliacs demonstrated a progressive decrease in the T4/T8 ratio and a progressive increase in the degree of IgG hypergammaglobulinemia as they aged. The amount of factor or cryoprecipitate or exposure to virus did not influence the T4/T8 ratio. These changes appear to be a result of chronic product exposure, which becomes more pronounced with increasing age.
Similar content being viewed by others
References
Larsson SA, Wiechel B: Deaths in Swedish hemophiliacs, 1957–1980. Acta Med Scand 214:199–206, 1983
Ikkala E, Helske T, Myllyla G, Nevanlinna HR, Pitanen P, Rasi V: Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930–1979. Br J Haematol 52:7–12, 1982
Cheeseman SH, Sullivan JL, Brettler DB, Levine PH: Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome. JAMA 252:83–85, 1984
Hruby MA, Schauf V: Transfusion-related short incubation hepatitis in hemophilic patients. JAMA 240:1355–1357, 1978
Spero JA, Lewis JH, Van Thiel DH, Hasiba U, Rubin BS: Asymptomatic structural liver disease in hemophilia. N Engl J Med 298:1373–1378, 1978
Melbye M, Madhok R, Sarin PS, Lowe GDO, Goedert JJ, Froebel KS, Biggar RJ, Stenbjerg S, Forbes CD, Gallo RC, Ebbesen P: HTLV-III seropositivity in European hemophiliacs exposed to factor VIII concentrate imported from the USA. Lancet 2:1444–1446, 1984
Koerper MA, Kaminsky LS, Levy JA: Differential prevalence of antibody to AIDS-associated retrovirus in hemophiliacs treated with factor VIII concentrate versus cryoprecipitate: Recovery of infectious virus. Lancet 1:275, 1985
Ammann AJ, Cowan MJ, Wara DW, Weintrub P, Dritz S, Goldman H, Perkins HA: Acquired immunodeficiency in an infant: Possible transmission by means of blood products. Lancet 1:956–958, 1983
Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland M, Weinstein R, Lui KJ, Schonberger LB, Spira TJ, Alexander WJ, Swinger G, Ammann A, Solomon S, Auerbach D, Mildvan D, Stoneburner R, Jason JM, Haverkos HW, Evatt BL: Acquired immune deficiency syndrome (AIDS): Associated with transfusions. N Engl J Med 310:69–75, 1984
Centers for Disease Control: Update: Acquired immune deficiency syndrome (AIDS) in persons with hemophilia. Morbid Mortal Week Rep 33:589–591, 1984
Centers for Disease Control: Update on AIDS—United States 1983. Morbid Mortal Week Rep 33:688–691, 1984
Carr R, Edmond E, Prescott RJ, Veitch SE, Peutherer JF, Steel CM, Ludlum CA: Abnormalities of circulating lymphocyte subsets in hemophiliacs in an AIDS-free population. Lancet 1:1431–1434, 1984
Lee CA, Bofill M, Janossy G, Thomas HC, Rizza CR, Kernoff PBA: Relationships between blood product exposure and immunologic abnormalities in English hemophiliacs. Br J Haematol 60:161–172, 1985
Menitove JE, Aster RH, Casper JT, Lauer SJ, Gottschall JL, Williams JE, Gill JC, Wheelver DV, Piaskowski Y, Kirchner P, Montgomery RR: T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med 308:83–86, 1983
Lederman MM, Ratnoff OD, Scillian JJ, Jones PK, Schacter B: Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 308:79–83, 1983
Mannucci PM, Gringeri A, Ammassari M, Mari D: Abnormalities of lymphocyte subsets are correlated with concentration consumption in asymptomatic Italian hemophiliacs treated with concentrate made from American plasma. Am J Hematol 17:167–176, 1984
Ceuppens JL, Vermylen J, Colaert J, Desmyter J, Gautama K, Stevens E, The AL, Vanham G, Vermylen C, and Yertraete M: Immunologic alterations in hemophiliacs treated with lyophilized factor VIII cryoprecipitate from volunteer donors. Thromb Haemostas 51:207–211, 1984
Gerstoft J, Bentsen K, Scheibel E, Dalsgard-Neilsen J, Gormsen J, Dickmeiss E: Alterations in T-lymphocyte subsets among Danish hemophiliacs: Relation to source of factor VIII preparations and high dose factor VIII treatment. Scand J Haematol 32:544–551, 1984
Gjerset GF, Martin PJ, Counts RB, Fast LD, Hansen JA: Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate. Blood 64:715–720, 1984
Lechner K, Niessner H, Bettelheim P, Deutsch E, Fusching I, Fuhrmann M, Hinterberger W, Kominger C, Neumann E, Liszka K, Knupp W, Mayr WR, Stingl G, Zeithuber U: T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates. Thromb Haemostas 50:552–556, 1983
Weintrub PS, Koerper MA, Addiego JE, Drew WL, Lennette ET, Miner R, Cowan MJ, Ammann AJ: Immunologic abnormalities in patients with hemophilia A. J Pediat 103:692–695, 1983
Boyum A: Ficoll-Hypaque method for separating mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21:77, 1968
Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S: Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: Evidence from studies of proliferative responses to SB antigens. J Immunol 131:152–157, 1983
Kung PC, Goldstein G: Functional and development compartments of human T lymphocytes. Vox Sang 39:121–124, 1980
Kung PC, Goldstein G, Reinherz EL, Schlossman SF: Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347–349, 1979
Masur H, Michelis MA, Greene JB, Onorato I, Van de Stowe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, Cunningham-Rundles S: An outbreak of community-acquiredPneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction. N Engl J Med 305:1431–1438, 1982
Reinherz EL, Morimoto C, Penta AC, Schlossman SF: Subpopulations of the T4+ inducer T cell subset man. Evidence for an amplifier population preferentially expressing Ia antigen upon activation. J Immunol 126:67–70, 1981
Rogozinski L, Bass A, Glickman E, Talle MA, Goldstein G, Wang J, Chess L, Thomas Y: The T4 surface antigen is involved in the induction of helper function. J Immunol 132:735–739, 1984
Reinherz EL, Kung PC, Goldstein G, Levy RH, Schlossman SF: Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci 77:1588–1592, 1980
Reinherz EL, Schlossman SF: The characterization and function of human immunoregulatory T lymphocyte subsets. Immunol Today 2:69–75, 1981
Reinherz EL, Schlossman SF: Regulation of the immune response-inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med 303:370–373, 1980
Reinherz EL, Kung PC, Goldstein G, Schlossman SF: A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol 124:1301–1307, 1980
Billing R, Rafizadeh B, Drew I, Hartman G, Gale R, Terasaki P: Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera. J Exp Med 144:167–178, 1976
Evans RI, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF: Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med 148:1440–1445, 1978
Fu SM, Chiorazzi N, Wang CY, Montazeri G, Kunkel HG, Ko HS, Gottlieb AB: Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogenic helper activity. J Exp Med 148:1423–1428, 1978
Lanier LL, Engleman EG, Gantenby P, Babcock GF, Warner NL, Herzenberg LA: Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometry. Immunol Rev 74:147–153, 1983
Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF: Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu 11 (NK-15) antigens. J Immunol 131:1789–1796, 1983
Aiuti F, Fontana L, Gatti RA: Membrane-bound immunoglobulin (Ig) and in vitro production of Ig by lymphoid cells from patients with primary immunodeficiency. Scand J Immunol 2:9–16, 1973
Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF: A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol 124:1943–1948, 1980
Todd RF, Nadler LM, Schlossman SF: Antigens on human monocytes identified by monoclonal antibodies. J Immunol 126:1435–1442, 1981
Gillis S, Ferm M, Ou W, Smith K: T cell growth factor: Parameters of production and quantitative microassay for activity. J Immunol 120:2027–2031, 1978
Luger TA, Smolen JS, Chused TM, Steinberg AD, Oppenheim JJ: Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest 70:470–473, 1982
Lizana J, Hellsing K: Polymer enhancement of automated immunological nephrometric analysis as illustrated by determination of urinary albumin. Clin Chem 20:415–420, 1974
Weiss SH, Goedert J, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA: Screening test for HTLV-III (AIDS agent) antibodies: Specificity, sensitivity, and applications. JAMA 253:221–225, 1985
Sendecor GW, Cochran WG: Statistical Methods, Ames, Iowa State University Press, 1980
Remington RD, Schork M: Regaression and correlation.In Statistics with Applications to Biological and Health Sciences, RD Remington, M Schork (eds). Englewood Cliffs, NJ, Prentice-Hall, 1970, pp 253–258
Lee CA, Kernoff PBA, Karayiannis P, Waters J, Thomas HC: Abnormal T-lymphocyte subsets in hemophilia: Relation to HLA proteins in plasma products. N Engl J Med 310:1058, 1984
Jason J, Hilgartner M, Holman RC, Dixon G, Spira TJ, Aldeort L, Evatt B: Immune status of blood product recipients. JAMA 253:1140–1145, 1985
Ragni MV, Lewis JH, Spero JA, Bontempo FA: Acquired-immunodeficiency like syndrome in two hemophiliacs. Lancet 1:213–214, 1983
Unzeitig JC, Church JA, Gomperts ED, Nye CA, Pasquale S, Richards W: Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate. AJDC 138:645–648, 1984
Crawford DH, Brickell P, Tidman N, McConnell I, Hoffbrand AV, Janossy G: Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol 42:291–297, 1981
Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF: The cellular basis for viral-induced immunodeficiency: Analysis by monoclonal antibodies. J Clin Immunol 125:1269–1273, 1980
Schooley RT, Hirsch MS, Colvin RB, Cosimi B, Tolkoff-Rubin NE, McCluskey RT, Burton RC, Russell PS, Herrin JT, Delmonico FL, Giorgi JV, Henle W, Rubin RH: Association of herpes virus infection with T-lymphocyte subset alterations, glomerulopathy, and opportunistic infections after rental transplantation. N Engl J Med 308:307–313, 1983
Anh-Tuan N, Novak E, Hollan S: Hepatitis B surface antigen circulating immune complexes (HBsAg-CiCs) in patients with bleeding disorders Vox Sang 40:12–16, 1981
Koller U, Majdic O, Liszka K, Stockinger H, Pabinger-Fasching I, Lechner K, Knapp W: Lymphocytes of hemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens. Clin Exp Immunol 59:613–621, 1985
Seki H, Taga K, Nagoki T, Barot-Ciorbaru R, Miyawaki T, Taniguchi N: Some evidence for thein vivo functional activation of suppressor T cells in asymptomatic patients with hemophilia A receiving factor VIII concentrates. Clin Immunol Immunopathol 34:27–38, 1985
Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Thim Fan P, Wolf RA, Saxon A:Pneumocystis carinii pneumonia and mucosal candidasis in previously healthy homosexual men. N Engl J Med 305:1425–1438, 1981
Schroff RW, Gottlieb MS, Prince HE, Chai LL, Fahey JL: Immunologic studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol 27:300–314, 1983
De Shazo RD, Andes WA, Nordberg J, Newton J, Daul C, Bozelka B: An immunologic evaluation of hemophiliac patients and their wives. Ann Intern Med 99:159–164, 1983
Popovic M, Sarnjadharan MG, Read E, Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500, 1984
Eyster ME, Goedert JJ, Sarngadharan MG, Weiss SH, Gallo RC, Blattner WA: Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA 253:2219–2253, 1985
Enlow RW, Roldan AN, LoGalbo P, Mildvan U, Mathur U, Winchester RJ: Increased frequency of HLA-DR5 in lymphadenopathy stages of AIDS. Lancet 2:51–52, 1983
Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JKA, Dixon G, Doxey M, Evatt BL: Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. JAMA 253:3409–3415, 1985
Lederman MM, Ratnoff OD, Evatt BL, McDougal JS: Acquisition of antibody to lymphadenopathy-associated virus in patients with classic hemophilia (factor VIII deficiency). Ann Intern Med 102:753–757, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shannon, B.T., Roach, J., Cheek-luten, M. et al. Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia. J Clin Immunol 6, 121–129 (1986). https://doi.org/10.1007/BF00918744
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918744